Search - tctmd.com

Displaying 61 - 77 of 77

Sort: Relevancy | Date

News Conference News ACC 2022

SPYRAL HTN-ON MED at 3 Years: Renal Denervation’s BP Impact Endures

Todd Neale

April 08, 2022

News Conference News ACC 2022

POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery

Todd Neale

April 06, 2022

News Conference News ACC 2022

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

Michael O'Riordan

April 02, 2022

News Daily News

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

Caitlin E. Cox

March 31, 2022

News Conference News ACC 2022

Pericardial Effusion Signals Worse Prognosis in COVID-19 Inpatients

Todd Neale

March 29, 2022

News Daily News

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Michael O'Riordan

March 28, 2022

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

L.A. McKeown

March 22, 2022

News Daily News

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

L.A. McKeown

March 17, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

Wrong BP Cuff Size May Lead to Wildly Inaccurate Readings

L.A. McKeown

March 02, 2022

News Daily News

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Caitlin E. Cox

February 22, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

News Daily News

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

Caitlin E. Cox

February 11, 2022

News Daily News

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

Yael L. Maxwell

February 09, 2022

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Daily News

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

Caitlin E. Cox

January 14, 2022

Advertisement

SPYRAL HTN-ON MED at 3 Years: Renal Denervation’s BP Impact Endures

POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

Pericardial Effusion Signals Worse Prognosis in COVID-19 Inpatients

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

More Evidence Links Breast Arterial Calcification and CVD Risk

Wrong BP Cuff Size May Lead to Wildly Inaccurate Readings

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content